Veterinary Medicines

RHINANVAC CERDOS

Not authorised
  • Pasteurella multocida, serogroup D, toxoid
  • Pasteurella multocida, serogroup D, strain P-934, Inactivated
  • Mannheimia haemolytica, serotype A2, strain NCTC 9380, Inactivated
  • Mycoplasma hyopneumoniae, strain VMRI-11, Inactivated
  • Haemophilus parasuis, strain NCTC 4557, Inactivated
  • Bordetella bronchiseptica, strain S-4212, Inactivated
Download as PDF

Product identification

Medicine name:
RHINANVAC CERDOS
Active substance:
  • Pasteurella multocida, serogroup D, toxoid
  • Pasteurella multocida, serogroup D, strain P-934, Inactivated
  • Mannheimia haemolytica, serotype A2, strain NCTC 9380, Inactivated
  • Mycoplasma hyopneumoniae, strain VMRI-11, Inactivated
  • Haemophilus parasuis, strain NCTC 4557, Inactivated
  • Bordetella bronchiseptica, strain S-4212, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Pasteurella multocida, serogroup D, toxoid
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Pasteurella multocida, serogroup D, strain P-934, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A2, strain NCTC 9380, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mycoplasma hyopneumoniae, strain VMRI-11, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Haemophilus parasuis, strain NCTC 4557, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Bordetella bronchiseptica, strain S-4212, Inactivated
    10.00
    antibody unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Syva S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2879 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download